Politan Capital sold $30K of VIR stock

Politan Capital, Dir of Vir Biotechnology, Inc. (VIR), sold 3,200 shares of VIR stock worth $30K, per an SEC Form 4 filed Jun 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 1, 2026, 1 day before it was made public.

VIR has moved +35.2% since the trade date, from $9.03 to $12.21 (Nov 6, 2026 close).